Rankings
▼
Calendar
QTTB FY 2021 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena
QTTB
Q32 Bio Inc.
$73M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$34M
+1157.3% YoY
Gross Profit
$24M
71.9% margin
Operating Income
-$96M
-282.4% margin
Net Income
-$96M
-281.9% margin
EPS (Diluted)
$-12.23
Cash Flow
Operating Cash Flow
-$110M
Free Cash Flow
-$112M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$212M
Total Liabilities
$42M
Stockholders' Equity
$170M
Cash & Equivalents
$108M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$34M
$3M
+1157.3%
Gross Profit
$24M
$3M
+804.0%
Operating Income
-$96M
-$130M
+26.3%
Net Income
-$96M
-$129M
+25.6%
← Q4 2020
All Quarters
Q1 2021 →